ArticleAntimicrobial agents and chemotherapy2002
Clinical strain of Pseudomonas aeruginosa carrying a bla(TEM-21) gene located on a chromosomal interrupted TnA type transposon.
Article in Antimicrobial agents and chemotherapy, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Current concepts in laboratory testing to guide antimicrobial therapy.Mayo Clinic proceedings · 2012Review
- The accessory genome of Pseudomonas aeruginosa.Microbiology and molecular biology reviews : MMBR · 2010Review
- Extended-spectrum-beta-lactamase-producing Enterobacteriaceae strains in various types of private health care centers.Antimicrobial agents and chemotherapy · 2007Article
- Clinical and molecular analysis of extended-spectrum {beta}-lactamase-producing enterobacteria in the community setting.Journal of clinical microbiology · 2005Article
- Prolonged outbreak of infection due to TEM-21-producing strains of Pseudomonas aeruginosa and enterobacteria in a nursing home.Journal of clinical microbiology · 2005Article
- Aminoglycoside resistance in Pseudomonas aeruginosa.Antimicrobial agents and chemotherapy · 2005Review
- Genetic environments of the rmtA gene in Pseudomonas aeruginosa clinical isolates.Antimicrobial agents and chemotherapy · 2004Article
- Extended-spectrum beta-lactamase-producing Enterobacteriaceae in community and private health care centers.Antimicrobial agents and chemotherapy · 2003Article
- Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact.Antimicrobial agents and chemotherapy · 2003Review
- Resistance mechanisms and therapeutic strategies forTherapeutic advances in infectious diseaseReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A clinical isolate of Pseudomonas aeruginosa was found to produce a clavulanic acid-inhibited extended-spectrum beta-lactamase with a pI of 6.4. PCR, cloning, and sequencing experiments showed that the corresponding bla(TEM-21) gene was part of a chromosomally located Tn801 transposon disrupted by an IS6100 element and adjacent to an aac(3)-II gene.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.